These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22421447)

  • 21. Selective targeting of HPV-16 E6/E7 in cervical cancer cells with a potent oncolytic adenovirus and its enhanced effect with radiotherapy in vitro and vivo.
    Wang W; Sima N; Kong D; Luo A; Gao Q; Liao S; Li W; Han L; Wang J; Wang S; Lu Y; Wang D; Xu G; Zhou J; Meng L; Ma D
    Cancer Lett; 2010 May; 291(1):67-75. PubMed ID: 19903581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
    Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
    Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
    Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The PEI-introduced CS shell/PMMA core nanoparticle for silencing the expression of E6/E7 oncogenes in human cervical cells.
    Saengkrit N; Sanitrum P; Woramongkolchai N; Saesoo S; Pimpha N; Chaleawlert-Umpon S; Tencomnao T; Puttipipatkhachorn S
    Carbohydr Polym; 2012 Oct; 90(3):1323-9. PubMed ID: 22939347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells.
    Choo CK; Ling MT; Suen CK; Chan KW; Kwong YL
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):293-301. PubMed ID: 10985883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7.
    Maher DM; Bell MC; O'Donnell EA; Gupta BK; Jaggi M; Chauhan SC
    Mol Carcinog; 2011 Jan; 50(1):47-57. PubMed ID: 21061268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Induction of human oral carcinoma by human papillomavirus 16 E6/E7 and TPA].
    Zhao J; Cao ZY; Sun YT; Liao QP; Du HJ; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):234-6. PubMed ID: 15340565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inhibitory effect of RNA interference on expression of HPV16 E6 oncogene in cervical cancer cell line CaSki].
    Niu XY; Peng ZL; Wang H
    Ai Zheng; 2004 Nov; 23(11):1257-62. PubMed ID: 15522169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gene characterization of E6 and E7 gene of human papillomavirus of 15 cervical cancer in Beijing].
    Ren Z; Wu HW; Song J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):88-90. PubMed ID: 20104743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo.
    Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D
    Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
    Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.
    Rincon-Orozco B; Halec G; Rosenberger S; Muschik D; Nindl I; Bachmann A; Ritter TM; Dondog B; Ly R; Bosch FX; Zawatzky R; Rösl F
    Cancer Res; 2009 Nov; 69(22):8718-25. PubMed ID: 19887612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of human papillomavirus 16 E5 on malignancy of human cervical cancer cells and the mechanism there of].
    Liao SJ; Deng DR; Xia X
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(43):3080-4. PubMed ID: 19192411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of human papillomavirus type 16 E6/E7 oncoproteins in cervical epithelial-mesenchymal transition and carcinogenesis.
    Cheng YM; Chou CY; Hsu YC; Chen MJ; Wing LY
    Oncol Lett; 2012 Mar; 3(3):667-671. PubMed ID: 22740973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of the malignant phenotype of cervical cancer CaSki cells through adeno-associated virus-mediated delivery of HPV16 E7 antisense RNA.
    Wu S; Meng L; Wang S; Wang W; Xi L; Tian X; Chen G; Wu Y; Zhou J; Xu G; Lu Y; Ma D
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2032-7. PubMed ID: 16609012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes.
    Caberg JH; Hubert PM; Begon DY; Herfs MF; Roncarati PJ; Boniver JJ; Delvenne PO
    Carcinogenesis; 2008 Jul; 29(7):1441-7. PubMed ID: 18566017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
    Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression, purification, and serum antibody detection of HPV16 E6 in cervical cancer patients].
    Gao YE; Guo JZ; Zhang J; Song TB; Yan XJ
    Ai Zheng; 2006 Nov; 25(11):1374-9. PubMed ID: 17094904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia.
    Ding DC; Chiang MH; Lai HC; Hsiung CA; Hsieh CY; Chu TY
    Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):215-20. PubMed ID: 19819061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HPV16-specific cytotoxic T lymphocyte responses are detected in all HPV16-positive cervical cancer patients.
    Valdespino V; Gorodezky C; Ortiz V; Kaufmann AM; Roman-Basaure E; Vazquez A; Berumen J
    Gynecol Oncol; 2005 Jan; 96(1):92-102. PubMed ID: 15589586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.